Azithromycin in Acute Coronary Syndrome - AZACS

Description:

The goal of Azithromycin in Acute Coronary Syndrome (AZACS) was to evaluate whether short-term treatment with azithromycin, a microlide antibiotic, can prevent death or further cardiac problems after unstable angina or acute myocardial infarction (MI) in patients with prior infection by chlamydia pneumoniae.